trapidil has been researched along with Cerebral Ischemia in 3 studies
Trapidil: A coronary vasodilator agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The experimental study presented was undertaken to evaluate the role of thromboxane A2 contributing to aggravating cerebral ischemia, and to examine the effect of a thromboxane A2 synthetase inhibitor, trapidil on cerebral ischemia." | 7.67 | [Protective effect of thromboxane A2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia]. ( Katayama, Y; Memezawa, H; Minamisawa, H; Shimizu, J; Sugimoto, S; Suzuki, S; Terashi, A, 1986) |
| "Cerebral ischemia was produced using bilateral common carotid artery occlusion in spontaneously hypertensive rats." | 5.28 | Role of arachidonic acid metabolism on ischemic brain edema and metabolism. ( Kamiya, T; Kashiwagi, F; Katayama, Y; Memezawa, H; Shimizu, J; Suzuki, S; Terashi, A, 1990) |
| "The experimental study presented was undertaken to evaluate the role of thromboxane A2 contributing to aggravating cerebral ischemia, and to examine the effect of a thromboxane A2 synthetase inhibitor, trapidil on cerebral ischemia." | 3.67 | [Protective effect of thromboxane A2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia]. ( Katayama, Y; Memezawa, H; Minamisawa, H; Shimizu, J; Sugimoto, S; Suzuki, S; Terashi, A, 1986) |
| "Trapidil has shown a more complete antithrombocytic activity than other antiaggregating drugs; as a matter of fact it inhibits the formation of TXA2 through a mechanism of receptorial antagonism and at the same time it favours an increase of prostacyclina from the arterial walls." | 2.38 | [Trapidil after one year]. ( Agus, GB, 1993) |
| "Cerebral ischemia was produced using bilateral common carotid artery occlusion in spontaneously hypertensive rats." | 1.28 | Role of arachidonic acid metabolism on ischemic brain edema and metabolism. ( Kamiya, T; Kashiwagi, F; Katayama, Y; Memezawa, H; Shimizu, J; Suzuki, S; Terashi, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agus, GB | 1 |
| Katayama, Y | 2 |
| Shimizu, J | 2 |
| Suzuki, S | 2 |
| Memezawa, H | 2 |
| Kashiwagi, F | 1 |
| Kamiya, T | 1 |
| Terashi, A | 2 |
| Minamisawa, H | 1 |
| Sugimoto, S | 1 |
1 review available for trapidil and Cerebral Ischemia
| Article | Year |
|---|---|
[Trapidil after one year].
Topics: Anticoagulants; Arm; Arteriosclerosis; Brain Ischemia; Clinical Trials as Topic; Drug Evaluation; Hu | 1993 |
2 other studies available for trapidil and Cerebral Ischemia
| Article | Year |
|---|---|
Role of arachidonic acid metabolism on ischemic brain edema and metabolism.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain Chemistry; Brain Edema; Brain Ischemia; Energy M | 1990 |
[Protective effect of thromboxane A2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia].
Topics: Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Cerebral Arteries; Lactates; Lactic Acid; Ma | 1986 |